Drug & supplement interaction

Branched-chain Amino Acids (bcaa) + nilotinib

nilotinib brand name: Tasigna.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Branched-chain Amino Acids (bcaa) and nilotinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Branched-chain Amino Acids (bcaa) and nilotinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between nilotinib and Branched-chain Amino Acids (bcaa) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Branched-chain Amino Acids (bcaa) safety at a glance

Branched-chain Ami... overall Use caution Generally well tolerated in healthy adults at typical supplement doses, but not appropriate for everyone.
Pregnancy Avoid Not enough safety data; avoid supplemental doses during pregnancy.
Breastfeeding Avoid Not enough safety data; avoid supplemental doses while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining nilotinib and Branched-chain Amino Acids (bcaa)? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for nilotinib

Interactions in our licensed database are recorded against drug classes, not just single drug names. nilotinib is filed under 9 classifications — including cytochrome p450 2c9 (cyp2c9) inhibitors, immunosuppressants, cytochrome p450 2d6 (cyp2d6) inhibitors. Branched-chain Amino Acids (bcaa) has documented interactions with 2 drug classes — the most serious being levodopa (major) and antidiabetes drugs (moderate) — and none of nilotinib’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Branched-chain Amino Acids (bcaa) Does Interact With Other Medications

Branched-chain Amino Acids (bcaa) has 5 major, 86 moderate known drug interactions in our database — nilotinib isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Branched-chain Amino Acids (bcaa)

Covers the 2,830 medications we’ve checked against Branched-chain Amino Acids (bcaa). Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Branched-chain Amino Acids (bcaa) and nilotinib May Share Several of the Same Side Effects

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do. One of them is worth acting on rather than waiting out — marked below.

  • Raised blood pressure Worth acting on Additional detail

    Branched-chain Amino Acids (bcaa)

    “Orally, a single case of hypertension following the use of BCAAs has been reported.”

    Branched-chain Amino Acids (bcaa) · Natural Medicines adverse-effect record, reported in hypertension.

    1 source cited
    1. 37143. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. The San-in Group of Liver Surgery. Br.J Surg. 1997;84(11):1525-1531. PubMed

    nilotinib

    Listed in the ADVERSE REACTIONS section of the FDA label for nilotinib. Read the label on DailyMed ›

  • Bloating or gas / Diarrhea / Vomiting / Nausea Additional detail

    Branched-chain Amino Acids (bcaa)

    “Orally, BCAAs can cause nausea, vomiting, diarrhea, and abdominal distension. Nausea and diarrhea has been reported to occur in about 10% of people taking BCAAs.”

    Branched-chain Amino Acids (bcaa) · Natural Medicines adverse-effect record, reported in diarrhea.

    4 sources cited
    1. 10117. Scarna A, Gijsman HJ, McTavish SF, et al. Effects of a branched-chain amino acid drink in mania. Br J Psychiatry 2003;182:210-3.. PubMed
    2. 37143. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. The San-in Group of Liver Surgery. Br.J Surg. 1997;84(11):1525-1531. PubMed
    3. 92643. Gluud LL, Dam G, Les I, et al. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev 2015;(9):CD001939. PubMed
    4. 97531. Gluud LL, Dam G, Les I, et al. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;5:CD001939. PubMed

    nilotinib

    Listed in the ADVERSE REACTIONS section of the FDA label for nilotinib. Read the label on DailyMed ›

  • Tiredness Additional detail

    Branched-chain Amino Acids (bcaa)

    “Orally and intravenously, BCAAs can cause fatigue and loss of motor coordination due to increased plasma ammonia levels. Short-term use of 60 grams of BCAAs containing leucine, isoleucine, and valine for 7 days in patients with normal metabolic function seems to increase levels of ammonia, but not to toxic plasma levels. However, liver function should be monitored with high doses or long-term use.”

    Branched-chain Amino Acids (bcaa) · Natural Medicines adverse-effect record, reported in cluster headache.

    5 sources cited
    1. 693. MacLean DA, Graham TE. Branched-chain amino acid supplementation augments plasma ammonia responses during exercise in humans. J Appl Physiol 1993;74:2711-7. PubMed
    2. 694. MacLean DA, Graham TE, Saltin B. Branched-chain amino acids augment ammonia metabolism while attenuating protein breakdown during exercise. Am J Physiol 1994;267:E1010-22.
    3. 10117. Scarna A, Gijsman HJ, McTavish SF, et al. Effects of a branched-chain amino acid drink in mania. Br J Psychiatry 2003;182:210-3.. PubMed
    4. 75. Institute of Medicine. The role of protein and amino acids in sustaining and enhancing performance. Washington, DC: National Academy Press, 1999. Available at: http://books.nap.edu/books/0309063469/html/309.html#pagetop DOI
    5. 681. Tandan R, Bromberg MB, Forshew D, et al. A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data. Neurology 1996;47:1220-6. PubMed

    nilotinib

    Listed in the ADVERSE REACTIONS section of the FDA label for nilotinib. Read the label on DailyMed ›

  • Headache Additional detail

    Branched-chain Amino Acids (bcaa)

    Recorded for Branched-chain Amino Acids (bcaa) in the same Natural Medicines adverse-effect record shown under Tiredness above.

    nilotinib

    Listed in the ADVERSE REACTIONS section of the FDA label for nilotinib. Read the label on DailyMed ›

Effects for nilotinib come from the ADVERSE REACTIONS section of its FDA label; effects for Branched-chain Amino Acids (bcaa) come from the Natural Medicines adverse-effect record, quoted above. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Everything else you take

See Every Supplement That Interacts With nilotinib

This page covers Branched-chain Amino Acids (bcaa) only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the nilotinib page lists 221 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), American Hellebore (major), Arsenic (major), Beer (major) and Cesium (major).

By severity: 11 major · 176 moderate · 34 minor.

From our pharmacist’s overview on the nilotinib page

“Nilotinib (Tasigna) is a targeted therapy for chronic myeloid leukemia, cleared by the liver enzyme CYP3A4 and known to affect heart rhythm, so its supplement list calls for genuine care. Eleven of the 221 ingredients here carry a major rating, and those belong at the top of your reading.”

Reviewed by 2 · Jul 18, 2026

Open the nilotinib interaction page

How much people look this up

Where Branched-chain Amino Acids (bcaa) and nilotinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Branched-chain Amino Acids (bcaa)
Steady interest

#1,286 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication nilotinib
Top half

#1,171 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Branched-chain Amino Acids (bcaa) reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Branched-chain Amino Acids (bcaa) and nilotinib records this page draws on were last updated July 11, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Branched-chain Amino Acids (bcaa)

What is Branched-chain Amino Acids (bcaa)?

  • Muscle building and exercise recovery
  • Reducing exercise fatigue
  • Preserving muscle during weight loss
  • Liver disease support
  • Tardive dyskinesia (under study)

Branched-chain amino acids (leucine, isoleucine, and valine) are essential nutrients commonly taken by athletes for muscle support and recovery. Evidence shows modest benefits for some uses, but a balanced protein source usually provides the same amino acids. They are generally well tolerated for most healthy adults, but check with your pharmacist or doctor before use, especially if you have a medical condition.

Powder, capsules, tablets, ready-to-drink beverages

An interaction check asks whether these two react with each other — it does not ask whether Branched-chain Amino Acids (bcaa) is a good idea for someone in your situation. Here is what our Branched-chain Amino Acids (bcaa) record says about it on its own.

Branched-chain Amino Acids (bcaa): dosing

There is no single official dose for BCAA supplements, and the amount used in studies has varied widely. Products differ in how much leucine, isoleucine, and valine they contain, and in the ratio between them.The best approach is to follow the directions on the product label and not take more than recommended.

From our Branched-chain Amino Acids (bcaa) monograph — the full record covers uses, side effects and every documented interaction.

Read the full Branched-chain Amino Acids (bcaa) monograph & all interactions
Medication

About Nilotinib

What Is Nilotinib Used For?

Brand name: Tasigna

  • Nilotinib is used to treat certain types of chronic myeloid leukemia (CML; a type of cancer of the white blood cells) who have recently found to have this condition in adults and children 1 year of age and older. It is also used to treat certain types of CML in adults whose disease could not be treated successfully with imatinib (Gleevec) or adults who cannot take imatinib because of side effects. Nilotinib is also used to treat certain types of CML in children 1 year of age or older whose disease could not be treated successfully with other tyrosine kinase inhibitor therapies or who cannot take these medications because of side effects. Nilotinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

See full Nilotinib drug information
Keep checking

Other Drugs & Branched-chain Amino Acids (bcaa)

Browse every other medication we’ve checked against Branched-chain Amino Acids (bcaa) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

5Major
86Moderate
0Minor
2,738No known interaction
Major

5 interactions

Moderate

86 interactions

Showing 60 of 86 moderate interactions — see all 86 on the Branched-chain Amino Acids (bcaa) page.

No interaction 2,738 drugs checked — show the list
Evidence & sources

Branched-chain Amino Acids (bcaa) References

The 20 references that drive our Branched-chain Amino Acids (bcaa) monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Rosen HM, Yoshimura N, Hodgman JM, Fischer JE. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 1977;72:483-7. DOI
  2. Institute of Medicine. The role of protein and amino acids in sustaining and enhancing performance. Washington, DC: National Academy Press, 1999. Available at: http://books.nap.edu/books/0309063469/html/309.html#pagetop DOI
  3. Tandan R, Bromberg MB, Forshew D, et al. A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data. Neurology 1996;47:1220-6. PubMed
  4. MacLean DA, Graham TE. Branched-chain amino acid supplementation augments plasma ammonia responses during exercise in humans. J Appl Physiol 1993;74:2711-7. PubMed
  5. MacLean DA, Graham TE, Saltin B. Branched-chain amino acids augment ammonia metabolism while attenuating protein breakdown during exercise. Am J Physiol 1994;267:E1010-22.
  6. DiPiro JT, Talbert RL, Yee GC, et al; eds. Pharmacotherapy: A pathophysiologic approach. 4th ed. Stamford, CT: Appleton & Lange, 1999.
  7. Nutt JG, Woodward WR, Hammerstad JP, et al. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med 1984;310:483-8. PubMed
  8. Baruzzi A, Contin M, Riva R, et al. Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients. Clin Neuropharmacol 1987;10:527-37. PubMed
  9. Juncos JL, Fabbrini G, Mouradian MM, et al. Dietary influences on the antiparkinsonian response to levodopa. Arch Neurol 1987;44:1003-5. PubMed
  10. Eriksson T, Granerus AK, Linde A, et al. "On-off" phenomenon in Parkinson's disease: relationship between dopa and other large neutral amino acids in plasma. Neurology 1988;38:1245-8. PubMed
  11. Hutson SM, Harris RA. Introduction. Symposium: Leucine as a nutritional signal. J Nutr 2001;131:839S-40S.
  12. Kimball SR, Jefferson LS. Control of protein synthesis by amino acid availability. Curr Opin Clin Nutr Metab Care 2002;5:63-7.. PubMed
  13. Anthony JC, Lang CH, Crozier SJ, et al. Contribution of insulin to the translational control of protein synthesis in skeletal muscle by leucine. Am J Physiol Endocrinol Metab 282:E1092-101.. PubMed
  14. Kimball SR, Farrell PA, Jefferson LS. Invited review: Role of insulin in translational control of protein synthesis in skeletal muscle by amino acids or excercise. J Appl Physiol 2002;93:1168-80..
  15. Scarna A, Gijsman HJ, McTavish SF, et al. Effects of a branched-chain amino acid drink in mania. Br J Psychiatry 2003;182:210-3.. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Branched-chain Amino Acids (bcaa) and nilotinib Together: Common Questions

Is it safe to take Branched-chain Amino Acids (bcaa) with nilotinib?
We do not list a known interaction between Branched-chain Amino Acids (bcaa) and nilotinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Branched-chain Amino Acids (bcaa) and nilotinib have any of the same side effects?
Yes — our sources link each of them separately to 7 of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
How was the Branched-chain Amino Acids (bcaa) and nilotinib combination checked?
Interactions in our licensed database are recorded against drug classes. nilotinib is filed under 9 classifications, and Branched-chain Amino Acids (bcaa) has documented interactions with 2 drug classes — none of nilotinib's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Branched-chain Amino Acids (bcaa) interact with any other medications?
Yes. Branched-chain Amino Acids (bcaa) has 91 documented drug interactions in our database — nilotinib is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does nilotinib interact with any supplements?
Yes. nilotinib has documented interactions with 221 supplements in our database — Branched-chain Amino Acids (bcaa) is not one of them. The nilotinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About nilotinib and Branched-chain Amino Acids (bcaa)?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.